183
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Computer Aided Drug Design of 1,2,3-Triazole Fused Bioactive Derivative Targeting Glucosamine-6-Phosphate Synthase (GlmS) – XRD, Computational Crystallography, and Molecular Simulation Approach

ORCID Icon, & ORCID Icon
Pages 3223-3239 | Received 30 Nov 2021, Accepted 07 Apr 2022, Published online: 09 May 2022

References

  • B. Malik and S. Bhattacharyya, “Antibiotic Drug-Resistance as a Complex System Driven by Socio-Economic Growth and Antibiotic Misuse,” Scientific Reports 9, no. 1 (2019): 1–12.
  • N. Woodford and M. J. Ellington, “The Emergence of Antibiotic Resistance by Mutation,” Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 13, no. 1 (2007): 5–18.
  • C. Llor and L. Bjerrum, “Antimicrobial Resistance: risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem,” Therapeutic Advances in Drug Safety 5, no. 6 (2014): 229–41.
  • N. Kerru, L. Gummidi, S. Maddila, K. K. Gangu, and S. B. Jonnalagadda, “A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications,” Molecules 25, no. 8 (2020): 1909. doi:10.3390/molecules25081909.
  • M. Gümüş, Ş. N. Babacan, Y. Demir, Y. Sert, İ. Koca, and İ. Gülçin, “Discovery of Sulfadrug–Pyrrole Conjugates as Carbonic Anhydrase and Acetylcholinesterase Inhibitors,” Archiv der Pharmazie 355, no. 1 (2022): 2100242. doi:10.1002/ardp.202100242.
  • İ. Çapan, M. Gümüş, H. Gökce, H. Çetin, Y. Sert, and İ. Koca, “Synthesis, Dielectric Properties, Molecular Docking and ADME Studies of Pyrrole-3-Ones,” Journal of Biomolecular Structure and Dynamics 39 (2021): 1–17. doi:10.1080/07391102.2021.1914174.
  • M. M. Heravi and V. Zadsirjan, “Prescribed Drugs Containing Nitrogen Heterocycles: An Overview,” RSC Advances 10, no. 72 (2020): 44247–311. doi:10.1039/D0RA09198G.
  • D. Dheer, V. Singh, and R. Shankar, “Medicinal Attributes of 1, 2, 3-Triazoles: Current Developments,” Bioorganic Chemistry 71 (2017): 30–54.
  • İ. Çapan, S. Servi, İ. Yıldırım, and Y. Sert, “Synthesis, DFT Study, Molecular Docking and Drug‐Likeness Analysis of the New Hydrazine‐1‐Carbothioamide, Triazole and Thiadiazole Derivatives: Potential Inhibitors of HSP90,” ChemistrySelect 6, no. 23 (2021): 5838–46. doi:10.1002/slct.202101086.
  • P. Patil, S. P. Sethy, T. Sameena, and K. Shailaja, “Pyridine and Its Biological Activity: A Review,” Asian Journal of Research in Chemistry 6, no. 10 (2013): 888–99.
  • A. A. Altaf, A. Shahzad, Z. Gul, N. Rasool, A. Badshah, B. Lal, and E. Khan, “A Review on the Medicinal Importance of Pyridine Derivatives,” Journal of Drug Design and Medicinal Chemistry 1, no. 1 (2015): 1–11.
  • V. Ivasiv, C. Albertini, A. E. Gonçalves, M. Rossi, and M. L. Bolognesi, “Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases,” Current Topics in Medicinal Chemistry 19, no. 19 (2019): 1694–711. doi:10.2174/1568026619666190619115735.
  • P. Durand, B. Golinelli-Pimpaneau, S. Mouilleron, B. Badet, and M.-A. Badet-Denisot, “Highlights of Glucosamine-6P Synthase Catalysis,” Archives of Biochemistry and Biophysics 474, no. 2 (2008): 302–17. doi:10.1016/j.abb.2008.01.026.
  • M. A. Badet-Denisot, L. Rene, and B. Badet, “Mechanistic Investigations on Glucosamine-6-Phosphate Synthase,” Bulletin de la Société Chimique de France 130, no. 3 (1993): 249–55.
  • S. Milewski, “Glucosamine-6-Phosphate Synthase-the Multi-Facets Enzyme,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1597, no. 2 (2002): 173–92. doi:10.1016/S0167-4838(02)00318-7.
  • R. Raja, A. Sivasubramaniyan, D. Murugan, N. Subbaiah, J. George, S. Poovan, N. Sangaraiah, P. Alagusundaram, K. Shanmugam, and C. Manivachagam, “A Green Synthesis of 1, 2, 3-Triazolyl-Pyridine Hybrids and Evaluation of Their Antibacterial Activity,” Research on Chemical Intermediates 42, no. 12 (2016): 8005–21. doi:10.1007/s11164-016-2575-y.
  • Bruker, A. X. S. Inc. Apex 2. Bruker advanced X-ray solutions, Madison, Wisconsin, USA (2004).
  • G. M. Sheldrick, SAINT-NT (version 6.04) (Madison, WI: Bruker Analytical X-ray Systems, 2001).
  • G. M. Sheldrick, SADABS (version 2.10) (Germany: University of Göttingen, 2003).
  • G. M. Sheldrick, “Crystal Structure Refinement with SHELXL,” Acta Crystallographica Section C: Structural Chemistry 71, no. 1 (2015): 3–8.
  • T. R. Schneider and G. M. Sheldrick, “Substructure Solution with SHELXD,” Acta Crystallographica Section D Biological Crystallography 58, no. 10 (2002): 1772–9. doi:10.1107/S0907444902011678.
  • L. J. Farrugia, “WinGX Suite for Small-Molecule Single-Crystal Crystallography,” Journal of Applied Crystallography 32, no. 4 (1999): 837–8. doi:10.1107/S0021889899006020.
  • A. L. Spek, “PLATON, an Integrated Tool for the Analysis of the Results of a Single Crystal Structure Determination,” Acta Crystallographica Section A: Foundations of Crystallography 46, no. s1 (1990): c34–c34.
  • C. F. Macrae, P. R. Edgington, P. McCabe, E. Pidcock, G. P. Shields, R. Taylor, M. Towler, and J. van de Streek, “Mercury: Visualization and Analysis of Crystal Structures,” Journal of Applied Crystallography 39, no. 3 (2006): 453–7. doi:10.1107/S002188980600731X.
  • M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, et al., Gaussian 09, Revision D.01 (Wallingford CT: Gaussian, Inc., 2009).
  • R. Dennington, T. A. Keith, and J. M. Millam, GaussView (version 6) (Shawnee Mission, KS: Semichem Inc., 2016).
  • M. J. Turner, J. J. McKinnon, S. K. Wolff, D. J. Grimwood, P. R. Spackman, D. Jayatilaka, and M. A. Spackman, CrystalExplorer (version 17) (Australia: University of Western Australia, 2017).
  • D. Douche, Y. Sert, S. A. Brandán, A. A. Kawther, B. Bilmez, N. Dege, A. El Louzi, K. Bougrin, K. Karrouchi, and B. Himmi, “5-((1H-Imidazol-1-yl) Methyl) Quinolin-8-ol as Potential Antiviral SARS-CoV-2 Candidate: Synthesis, Crystal Structure, Hirshfeld Surface Analysis, DFT and Molecular Docking Studies,” Journal of Molecular Structure 1232 (2021): 130005.
  • C. Jelsch, K. Ejsmont, and L. Huder, “The Enrichment Ratio of Atomic Contacts in Crystals, an Indicator Derived from the Hirshfeld Surface Analysis,” IUCrJ 1, no. Pt 2 (2014): 119–28. doi:10.1107/S2052252514003327.
  • P. R. Spackman, M. J. Turner, J. J. McKinnon, S. K. Wolff, D. J. Grimwood, D. Jayatilaka, and M. A. Spackman, “CrystalExplorer: A Program for Hirshfeld Surface Analysis, Visualization and Quantitative Analysis of Molecular Crystals,” Journal of Applied Crystallography 54, no. 3 (2021): 1006–11. doi:10.1107/S1600576721002910.
  • C. F. Mackenzie, P. R. Spackman, D. Jayatilaka, and M. A. Spackman, “CrystalExplorer Model Energies and Energy Frameworks: Extension to Metal Coordination Compounds, Organic Salts, Solvates and Open-Shell Systems,” IUCrJ 4, no. Pt 5 (2017): 575–87.
  • S. Dallakyan and A. J. Olson, “Small-Molecule Library Screening by Docking with PyRx,” in Chemical Biology. (New York, NY: Humana Press, 2015), 243–50.
  • O. Trott and A. J. Olson, “AutoDock Vina: improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading,” Journal of Computational Chemistry 31, no. 2 (2010): 455–61.
  • D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, and J. Woolsey, “Drugbank: A Comprehensive Resource for in Silico Drug Discovery and Exploration,” Nucleic Acids Research 34, no. Database issue (2006): D668–72. doi:10.1093/nar/gkj067.
  • “Glucosamine-6-Phosphate Synthase In Complex With Glucosamine-6-Phosphate,” https://www.rcsb.org/structure/2vf5
  • Dassault Systemes Biovia, Biovia Discovery Studio Visualizer, v16.1.0 (San Diego: Dassault - Systemes, 2016).
  • S. A. Hollingsworth, and R. O. Dror, “Molecular Dynamics Simulation for All,” Neuron 99, no. 6 (2018): 1129–43.
  • Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2021. Maestro-Desmond Interoperability Tools (New York, NY: Schrödinger, 2021).
  • M. A. Almehmadi, A. Aljuhani, S. Y. Alraqa, I. Ali, N. Rezki, M. R. Aouad, and M. Hagar, “Design, Synthesis, DNA Binding, Modeling, Anticancer Studies and DFT Calculations of Schiff Bases Tethering Benzothiazole-1, 2, 3-Triazole Conjugates,” Journal of Molecular Structure 1225 (2021): 129148. doi:10.1016/j.molstruc.2020.129148.
  • I. S. Murthy, R. Sreenivasulu, G. Alluraiah, and R. R. Raju, “Design, Synthesis, and Anticancer Activity of 1, 2, 3-Triazole Linked 1, 2-Isoxazole-Imidazo [4, 5-b] Pyridine Derivatives,” Russian Journal of General Chemistry 89, no. 8 (2019): 1718–23. doi:10.1134/S1070363219080279.
  • M. N. Ahmed, S. Shabbir, B. Batool, T. Mahmood, U. Rashid, K. A. Yasin, M. N. Tahir, M. L. Arias Cassará, and D. M. Gil, “A New Insight into Non-Covalent Interactions in 1, 4-Disubstituted 1H-1, 2, 3-Triazole: Synthesis, X-Ray Structure, DFT Calculations, in Vitro Lipoxygenase Inhibition (LOX) and in Silico Studies,” Journal of Molecular Structure 1236 (2021): 130283. doi:10.1016/j.molstruc.2021.130283.
  • S. Sun, C. Reep, C. Zhang, B. Captain, R. Peverati, and N. Takenaka, “Design and Synthesis of 3, 3′-Triazolyl Biisoquinoline N, N’-Dioxides via Hiyama Cross-Coupling of 4-Trimethylsilyl-1, 2, 3-Triazoles,” Tetrahedron Letters 81 (2021): 153338. doi:10.1016/j.tetlet.2021.153338.
  • D. Pegu, J. Deb, C. Van Alsenoy, and U. Sarkar, “Theoretical Investigation of Electronic, Vibrational, and Nonlinear Optical Properties of 4-Fluoro-4-Hydroxybenzophenone,” Spectroscopy Letters 50, no. 4 (2017): 232–43. doi:10.1080/00387010.2017.1308381.
  • T. Tsuneda, J. W. Song, S. Suzuki, and K. Hirao, “On Koopmans’ Theorem in Density Functional Theory,” The Journal of Chemical Physics 133, no. 17 (2010): 174101.
  • A. M. Vijesh, A. M. Isloor, S. Telkar, T. Arulmoli, and H. K. Fun, “Molecular Docking Studies of Some New Imidazole Derivatives for Antimicrobial Properties,” Arabian Journal of Chemistry 6, no. 2 (2013): 197–204. doi:10.1016/j.arabjc.2011.10.007.
  • M. A. Ezeokonkwo, O. N. Ogbonna, S. N. Okafor, E. U. Godwin-Nwakwasi, F. N. Ibeanu, and U. C. Okoro, “Angular Phenozaxine Ethers as Potent Multi-Microbial Targets Inhibitors: design, Synthesis, and Molecular Docking Studies,” Frontiers in Chemistry 5 (2017): 107. doi:10.3389/fchem.2017.00107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.